Research Topics
| D L LeslieSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Changes in inpatient mental health utilization and costs in a privately insured population, 1993 to 1995D L Leslie
Connecticut Massachusetts VA Mental Illness Research, Education and Clinical Center, Department of Psychiatry, Yale School of Medicine, West Haven, CT 06516, USA
Med Care 37:457-68. 1999..Concerns over rising health care costs have led to pressure on health care providers to reduce inpatient costs...
Health care expenditures associated with autism spectrum disordersDouglas L Leslie
Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA
Arch Pediatr Adolesc Med 161:350-5. 2007..To examine the health care expenditures associated with autism spectrum disorders (ASDs) in medical care settings...
Premature death associated with delirium at 1-year follow-upDouglas L Leslie
Department of Psychiatry, Yale University School of Medicine, New Haven, Conn, USA
Arch Intern Med 165:1657-62. 2005..The objective of this study is to estimate the fraction of a year of life lost associated with delirium at 1-year follow-up...
Pharmacotherapy and health care costs among patients with schizophrenia and newly diagnosed diabetesDouglas L Leslie
Department of Psychiatry at Yale University in West Haven, Connecticut 06516, USA
Psychiatr Serv 56:803-9. 2005..This study investigated how antipsychotic pharmacotherapy and health care costs change after diabetes mellitus is newly diagnosed among patients with schizophrenia...
Consequences of preventing delirium in hospitalized older adults on nursing home costsDouglas L Leslie
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
J Am Geriatr Soc 53:405-9. 2005..To determine whether costs of long-term nursing home (NH) care for patients who received a multicomponent targeted intervention (MTI) to prevent delirium while hospitalized were less than for those who did not receive the intervention...
Adherence of schizophrenia pharmacotherapy to published treatment recommendations: patient, facility, and provider predictorsDouglas L Leslie
Yale University School of Medicine, NEPEC 182, 950 Campbell Ave, West Haven, CT 06516, USA
Schizophr Bull 30:649-58. 2004..When patients were dosed outside of the recommendations, patients treated at facilities with more emphasis on mental health and research and education were more likely to be dosed above the recommendations...
Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medicationsDouglas L Leslie
Department of Veterans Affairs Connecticut Mental Illness Research, Education and Clinical Center, West Haven, CT, USA
Am J Psychiatry 161:1709-11. 2004..The purpose of the study was to determine the proportion of patients with schizophrenia with a stable regimen of antipsychotic monotherapy who developed diabetes or were hospitalized for ketoacidosis...
Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sectorDouglas L Leslie
Department of Psychiatry, Yale School of Medicine, VA Connecticut Mental Illness Research, Education and Clinical Center, West Haven VAMC, West Haven, CT 06516, USA
J Ment Health Policy Econ 6:113-21. 2003..This study used measures of the quality of pharmacotherapy for patients with schizophrenia and compared these measures across a sample of patients from the Department of Veterans Affairs (VA) and the private sector...
Inpatient treatment of comorbid psychiatric and substance abuse disorders: comparison of public sector and privately insured populationsD L Leslie
Connecticut Massachusetts VA Mental Illness Research, Education and Clinical Center, USA
Adm Policy Ment Health 26:253-68. 1999..Although the substantial differences in the populations treated could account for the differences in these measures across systems, this study is useful in illustrating the possibilities and limitations of system comparisons...
Shifting to outpatient care? Mental health care use and cost under private insuranceD L Leslie
Connecticut Massachusetts VA Mental Illness Research, Education, and Clinical Center, West Haven, USA
Am J Psychiatry 156:1250-7. 1999..Concern over rising health care costs has put pressure on providers to reduce costs, purportedly by reducing inpatient care and increasing outpatient care...
Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictorsD L Leslie
VA Connecticut Mental Illness Research, Education and Clinical Center, West Haven, CT, USA
Med Care 39:923-33. 2001..This paper presents a profile of the use of antipsychotic medications in the treatment of schizophrenia in a national health system...
Comparing quality of mental health care for public-sector and privately insured populationsD L Leslie
Northeast Program Evaluation Center, Connecticut Massachusetts VA Mental Illness Research, Education, and Clinical Center, West Haven, Connecticut 06516, USA
Psychiatr Serv 51:650-5. 2000..It demonstrated methods for measuring quality of mental health care and, using these measures, compared patients from Department of Veterans Affairs (VA) hospitals with privately insured patients...
The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophreniaD L Leslie
VA Connecticut Mental Illness Research, Education and Clinical Center, West Haven, USA
J Nerv Ment Dis 189:377-83. 2001..Institutional fiscal pressure does not seem to reduce the broad availability of these medications overall but does affect which drug is prescribed...
From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medicationsDouglas L Leslie
Department of Psychiatry, Yale School of Medicine, CT, USA
Am J Psychiatry 159:1534-40. 2002..Quetiapine was the least prescribed of the newer drugs. These results suggest that it is important that all of these medications are included in formularies...
Patterns of mental health utilization and costs among children in a privately insured populationD L Leslie
Northeast Program Evaluation Center, West Haven, CT 06516, USA
Health Serv Res 36:113-27. 2001..CONCLUSIONS: Changes in mental health service delivery have resulted in substantially reduced access to mental health care among children and significant declines in service use and costs among those who do receive services...
Depressive symptoms and the risk of incident delirium in older hospitalized adultsGail J McAvay
Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA
J Am Geriatr Soc 55:684-91. 2007..To determine whether specific subsets of symptoms from the Geriatric Depression Scale (GDS), assessed at hospital admission, were associated with the incidence of delirium...
Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer diseaseRobert A Rosenheck
Northeast Program Evaluation Center 182, VA Connecticut Health Care System, West Haven, Connecticut 06516, USA
Arch Gen Psychiatry 64:1259-68. 2007..Second-generation antipsychotics (SGAs) are prescribed for psychosis, aggression, and agitation in Alzheimer disease (AD)...
Second-generation antipsychotics: cost-effectiveness, policy options, and political decision makingRobert A Rosenheck
Department of Psychiatry, Yale Medical School, New Haven, CT 06516, USA
Psychiatr Serv 59:515-20. 2008..High expenditures on these medications are thus likely to continue without concomitant gains for public health...
Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans AffairsSomaia Mohamed
Northeast Program Evaluation Center, Department of Psychiatry, Yale School of Medicine, VA Connecticut Health Care System, West Haven, CT 06516, USA
J Clin Psychiatry 70:906-12. 2009....
Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?Susan H Busch
Yale School of Public Health, P O Box 208034, Suite 300, New Haven, CT 06520 8034, USA
Psychiatr Serv 61:11-6. 2010..Although researchers have documented a decline in antidepressant use among children over this period, less is known about whether specific safety information conveyed in individual warnings was reflected in treatment patterns...
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophreniaRobert A Rosenheck
University of North Carolina, Chapel Hill, USA
Am J Psychiatry 163:2080-9. 2006..Second-generation antipsychotics have largely replaced first-generation antipsychotics for the treatment of schizophrenia, but a large-scale cost/effectiveness analysis has not been attempted...
Older adults discharged from the hospital with delirium: 1-year outcomesGail J McAvay
Department of Internal Medicine, School of Medicine, Yale University, New Haven, Connecticut 06510, USA
J Am Geriatr Soc 54:1245-50. 2006..To compare 1-year institutionalization and mortality rates of patients who were delirious at discharge, patients whose delirium resolved by discharge, and patients who were never delirious in the hospital...
Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample databaseDanil V Makarov
Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, Connecticut 06520, USA
J Urol 183:1504-9. 2010..We determined whether state level variation in the cost of radical prostatectomy exists and whether we could explain this variation by adjusting for covariates associated with cost...
Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisionsJennifer Hoblyn
Palo Alto Veterans Affairs Health Care System, Sierra Pacific Mental Illness Research, Education, and Clinical Center, Palo Alto, CA 94304, USA
J Psychiatr Res 40:160-6. 2006..Off-label prescribing of medications, polypharmacy, and other questionable prescribing practices have led investigators to examine a large VA pharmacy database to determine if physician prescribing decisions appear reasonable...
Changes in child and adolescent inpatient psychiatric admission diagnoses between 1995 and 2000Ilan Harpaz-Rotem
Department of Psychiatry, Yale University School of Medicine, 25 Park Street GEB 617, New Haven, CT, 06519, USA
Soc Psychiatry Psychiatr Epidemiol 40:642-7. 2005..This study lends support to recent concerns that the prevalence of bipolar disorder among the youth is increasing. Further research is needed to identify the underlying reasons for these observed changes...
Undiagnosed hyperglycemia in clozapine-treated patients with schizophreniaMichael J Sernyak
Psychiatry Service, VA Connecticut Healthcare System, and Yale University School of Medicine, New Haven, Conn, USA
J Clin Psychiatry 64:605-8. 2003..This study was designed to investigate the proportion of undiagnosed impaired fasting glucose and diabetes mellitus in patients prescribed clozapine at 8 Department of Veterans Affairs (VA) medical centers...
A chart-based method for identification of delirium: validation compared with interviewer ratings using the confusion assessment methodSharon K Inouye
Yale University School of Medicine, Department of Internal Medicine, New Haven, CT 06520, USA
J Am Geriatr Soc 53:312-8. 2005..To validate a chart-based method for identification of delirium and compare it with direct interviewer assessment using the Confusion Assessment Method (CAM)...
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophreniaMichael J Sernyak
Psychiatry Service, VA Connecticut Healthcare System, West Haven, 06516, USA
Am J Psychiatry 159:561-6. 2002..This study used administrative data from a large national sample of patients with a diagnosis of schizophrenia to compare the prevalence of diabetes mellitus in patients receiving prescriptions for atypical and typical neuroleptics...
Comparing the quality of antidepressant pharmacotherapy in the Department of Veterans Affairs and the private sectorSusan H Busch
Department of Health Policy, Yale School of Medicine, New Haven, Connecticut 06520 8034, USA
Psychiatr Serv 55:1386-91. 2004..This study compared measures of the quality of pharmacotherapy for patients with major depression across a sample of patients from the Department of Veterans Affairs (VA) and the private sector...
Rethinking antipsychotic formulary policyR A Rosenheck
Yale Medical School, New Haven, CT, USA
Schizophr Bull 34:375-80. 2008..The algorithm outlined here and the process for its implementation are intended as a stimulus for discussion of potential policy responses, not as a finalized proposition...
Policy implications of CATIERobert A Rosenheck
Psychiatr Serv 59:695. 2008
One-year health care costs associated with delirium in the elderly populationDouglas L Leslie
Department of Health Administration and Policy, Medical University of South Carolina, 151 Rutledge Ave, Bldg B, PO Box 250961, Charleston, SC 29425, USA
Arch Intern Med 168:27-32. 2008..While delirium has been increasingly recognized as a serious and potentially preventable condition, its long-term implications are not well understood. This study determined the total 1-year health care costs associated with delirium...
Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured populationEdward Alan Miller
A. Alfred Taubman Center for Public Policy and American Institutions, Brown University, 67 George Street, Providence, RI 02912, USA
J Nerv Ment Dis 193:387-95. 2005..01) or quetiapine (HR = 0.50; p < 0.10), while diabetes risk among females did not differ significantly from first-generation antipsychotics for any atypical examined. These findings are substantially different from other reports...
Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptylineMugdha Gore
Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
Pain Pract 6:265-72. 2006..However, the clinical significance of these data is, as yet, unclear. Although, in theory, adverse outcomes may have been associated with this practice, we could not confirm this with this database analysis...
